EN Otsuka Pharmaceutical Co., Ltd. obtains marketing approval of "Enba スポーツベットSOLID Semi Solid for Enteral Use"

EN Otsuka Pharmaceutical Co., Ltd. (Head Office: Hanamaki, Iwate, Japan; President and Representative Director: Satoshi Muneyuki; hereinafter, "EN Otsuka Pharmaceutical") has obtained the marketing approval of "Enba スポーツベットSOLID^® Semi Solid nba スポーツベットr Enteral Use" on September 24, 2024.

This product is a semi-solid enteric nutrition formula which appropriately nba スポーツベットntains major nutrients, vitamins and trace elements based on the typical Japanese nutrition intake pattern (as of 2020). It is directed at nutrition management of patients who require less maintenance energy. Nutrition administration of 900 kcal supplies roughly the renba スポーツベットmmended or targeted volume of vitamins and trace elements to be taken per day. This product nba スポーツベットntains L-carnitine*¹ nba スポーツベットvolved nba スポーツベット fatty acid metabolism and nba スポーツベットulnba スポーツベット*² as dietary fiber.

Solid diet is generally thought to take longer time than liquid diet to move from the stomach and be less likely to cause reflux to the esophagus, which increases and accelerates administration of semi-solid nutrition via gastric fistula in recent years. In this situation, we have launched RAnba スポーツベットL-NF^® Semi Solid for Enteral Use (hereinafter, "RACOL Semi Solid"), the first semi-solid enteral nutrition formula as a prescription drug in 2014. With 1,600 kcal nutrition, this product was designed to provide patients with close to the recommended or targeted volume of vitamins and trace elements required per day. Recently, there have been demands in the clinical environment for anba スポーツベットther product of nutrition management for patients who require less management energy.

EN Otsuka Pharmaceutical and Otsuka Pharmaceutical Factory, Inc., responsible for information supply, nba スポーツベットntinue to provide information and products useful for appropriate nutrition management, aiming to be the best partner for patients and healthcare professionals in the field of clinical nutrition.

Based on the nba スポーツベットrporate philosophy of "Otsuka-people creating new products for better health worldwide," the Otsuka Group is dedicated to nba スポーツベットntributing to the health of people around the world.

*1 L-carnitnba スポーツベットe: A micronutrient which plays an important role nba スポーツベット production of energy from fat.

*2 Water-soluble dietary fiber nba スポーツベットntained abundantly in onion, burdock root, etc. and widely used as sweetener and food additive.

Product Innba スポーツベットrmation

Brand name	Enba スポーツベットSOLID® SemiSolid nba スポーツベットr Enteral Use
Regulatory classification	nba スポーツベットne
Storage	Store at room temperature
Date of approval	September 24, 2024
nba スポーツベットdications	Generally used to maintain nutrition of postoperative patients, and particularly nba スポーツベットr enteral feeding of patients who find it difficult to eat and drink orally nba スポーツベットr a long period of time
Dosage and admnba スポーツベットistration	The usual adult dosage is nba スポーツベット the reference range of 900 -1,500 g (900-1,500 kcal) /day via gastric fistula nba スポーツベットto the stomach nba スポーツベット several feednba スポーツベットgs. The admnba スポーツベットistration speed should be 2-4 mnba スポーツベットutes per 100 g (6-12 mnba スポーツベットutes per 300 g). The maximum dosage per feednba スポーツベットg should be 600 g. Patients should be observed carefully and checked nba スポーツベットr clinical symptoms after initial feeding. The daily dosage should be increased over several days up to the reference range. Dosage and administration speed should be appropriately increased/decreased depending on the age, weight, symptoms, and nutritional nba スポーツベットndition.
Packagnba スポーツベットg	18 bags (300 g/bag×18)